207 related articles for article (PubMed ID: 34613998)
21. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
22. Oct4 is a critical regulator of stemness in head and neck squamous carcinoma cells.
Koo BS; Lee SH; Kim JM; Huang S; Kim SH; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
Oncogene; 2015 Apr; 34(18):2317-24. PubMed ID: 24954502
[TBL] [Abstract][Full Text] [Related]
23. The emerging roles of Oct4 in tumor-initiating cells.
Wang YJ; Herlyn M
Am J Physiol Cell Physiol; 2015 Dec; 309(11):C709-18. PubMed ID: 26447206
[TBL] [Abstract][Full Text] [Related]
24. Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis.
Hu T; Liu S; Breiter DR; Wang F; Tang Y; Sun S
Cancer Res; 2008 Aug; 68(16):6533-40. PubMed ID: 18701476
[TBL] [Abstract][Full Text] [Related]
25. The Oct-1 POU-specific domain can stimulate small nuclear RNA gene transcription by stabilizing the basal transcription complex SNAPc.
Mittal V; Cleary MA; Herr W; Hernandez N
Mol Cell Biol; 1996 May; 16(5):1955-65. PubMed ID: 8628262
[TBL] [Abstract][Full Text] [Related]
26. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
27. OCT4 is up-regulated by DNA hypomethylation of promoter in recurrent gliomas.
Wu Y; Sun B; Shi W; Ni L; Chen J; Cai G; Shi J
Neoplasma; 2016; 63(3):378-84. PubMed ID: 26925786
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
[TBL] [Abstract][Full Text] [Related]
29. Investigation of specific binding of designed oligodeoxynucleotide decoys to transcription factors in HT29 cell line undergoing epithelial-mesenchymal transition (EMT).
Bigdelou Z; Johari B; Kadivar M; Rismani E; Asadi Z; Rahmati M; Saltanatpour Z
J Cell Physiol; 2019 Dec; 234(12):22765-22774. PubMed ID: 31115051
[TBL] [Abstract][Full Text] [Related]
30. Segments of the POU domain influence one another's DNA-binding specificity.
Aurora R; Herr W
Mol Cell Biol; 1992 Feb; 12(2):455-67. PubMed ID: 1732727
[TBL] [Abstract][Full Text] [Related]
31. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
[TBL] [Abstract][Full Text] [Related]
32. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
33. Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma.
Zhao S; Yuan Q; Hao H; Guo Y; Liu S; Zhang Y; Wang J; Liu H; Wang F; Liu K; Ling EA; Hao A
J Pathol; 2011 Apr; 223(5):672-82. PubMed ID: 21341266
[TBL] [Abstract][Full Text] [Related]
34. Targeting of replicating CD133 and OCT4/SOX2 expressing glioma stem cells selects a cell population that reinitiates tumors upon release of therapeutic pressure.
Guerra-Rebollo M; Garrido C; Sánchez-Cid L; Soler-Botija C; Meca-Cortés O; Rubio N; Blanco J
Sci Rep; 2019 Jul; 9(1):9549. PubMed ID: 31267022
[TBL] [Abstract][Full Text] [Related]
35. Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells.
Chang CJ; Chien Y; Lu KH; Chang SC; Chou YC; Huang CS; Chang CH; Chen KH; Chang YL; Tseng LM; Song WS; Wang JJ; Lin JK; Huang PI; Lan YT
Biochem Biophys Res Commun; 2011 Nov; 415(2):245-51. PubMed ID: 22037460
[TBL] [Abstract][Full Text] [Related]
36. Positive Feedback Loop of OCT4 and c-JUN Expedites Cancer Stemness in Liver Cancer.
Kuo KK; Lee KT; Chen KK; Yang YH; Lin YC; Tsai MH; Wuputra K; Lee YL; Ku CC; Miyoshi H; Nakamura Y; Saito S; Wu CC; Chai CY; Eckner R; Steve Lin CL; Wang SS; Wu DC; Lin CS; Yokoyama KK
Stem Cells; 2016 Nov; 34(11):2613-2624. PubMed ID: 27341307
[TBL] [Abstract][Full Text] [Related]
37. Oct4 is expressed in human gliomas and promotes colony formation in glioma cells.
Du Z; Jia D; Liu S; Wang F; Li G; Zhang Y; Cao X; Ling EA; Hao A
Glia; 2009 May; 57(7):724-33. PubMed ID: 18985733
[TBL] [Abstract][Full Text] [Related]
38. Reprogramming Transcription Factors Oct4 and Sox2 Induce a BRD-Dependent Immunosuppressive Transcriptome in GBM-Propagating Cells.
Ma T; Hu C; Lal B; Zhou W; Ma Y; Ying M; Prinos P; Quiñones-Hinojosa A; Lim M; Laterra J; Li Y
Cancer Res; 2021 May; 81(9):2457-2469. PubMed ID: 33574085
[TBL] [Abstract][Full Text] [Related]
39. Cooperative DNA Recognition Modulated by an Interplay between Protein-Protein Interactions and DNA-Mediated Allostery.
Merino F; Bouvier B; Cojocaru V
PLoS Comput Biol; 2015 Jun; 11(6):e1004287. PubMed ID: 26067358
[TBL] [Abstract][Full Text] [Related]
40. Selective influence of Sox2 on POU transcription factor binding in embryonic and neural stem cells.
Mistri TK; Devasia AG; Chu LT; Ng WP; Halbritter F; Colby D; Martynoga B; Tomlinson SR; Chambers I; Robson P; Wohland T
EMBO Rep; 2015 Sep; 16(9):1177-91. PubMed ID: 26265007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
